<DOC>
	<DOCNO>NCT00803387</DOCNO>
	<brief_summary>Although Benzalkonium chloride ( BAC ) use preservative many year , many study demonstrate prolonged use topical ocular medication preserve BAC may exacerbate sequela associate ocular surface disease . These effect could lead induction subclinical inflammation,1 reduction corneal epithelial barrier function , 2 , 3 destabilization tear film , 4 cataract formation , 5 overall high incidence patient complaint dryness irritation . 4-6 This study compare efficacy travoprost 0.004 % without benzalkonium chloride ( BAC ) market formulation latanoprost 0.005 % BAC patient dryness irritation open-angle glaucoma ocular hypertension . A double blind comparison use assess whether two different formulation affect tear breakup time , corneal staining , baseline tear secretion test patient already take latanoprost regularly complaint dryness irritation . Patients include study give two bottle , one label right eye leave eye . Each pair bottle identical appearance randomize either latanoprost travoprost pair assign number aid future analysis final result .</brief_summary>
	<brief_title>Dry Eye Irritation Comparison Latanoprost With Preservative Versus Travoprost Without Preservative</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>patient must already use xalatan least 1 month prior study enrollment eye complaint dry eye and/or irritation . study population : race either sex , diagnose open angle glaucoma ( OAG ) ( without pseudoexfoliation pigment dispersion component ) ocular hypertension ( OHT ) tear break time ( TBUT ) &lt; 6 second xalatan monotherapy . unequal baseline measurement ( i.e . difference cup disc ratio .1 great , intraocular pressure difference 2 mm Hg ) , difference subjective symptom dryness/irritation patient 's two eye ; history ocular trauma intraocular surgery within past 6 month either eye ; ocular infection , ocular inflammation , ocular laser surgery within past 3 month either eye ; severe hypersensitivity study medication vehicle ; abnormality prevent reliable applanation tonometry ; anterior chamber angle le 10 degree either eye , severe central visual field loss either eye ; cuptodisc ratio great 0.80 either eye ; contraindication pupil dilation ; previous diagnosis autoimmune disease ; chronic glucocorticoid use within 1 month eligibility phase intermittent glucocorticoid use within 2 week eligibility phase ; type glaucoma OAG OHT ; therapy another investigational agent within 30 day study start ; use topical systemic ocular hypotensive medication study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>ocular dryness</keyword>
	<keyword>ocular irritation</keyword>
	<keyword>open-angle glaucoma</keyword>
	<keyword>ocular hypertension</keyword>
	<keyword>TravatanZ</keyword>
	<keyword>Xalatan</keyword>
</DOC>